TMRW safeguards the world’s most precious cells for life. The TMRW platform revolutionizes the management, identification, and storage of fertility cells, replacing the manual and analog methods that have remained largely unchanged since IVF was first used in animal husbandry more than 50 years ago. Developed in partnership with leading fertility doctors and embryologists, TMRW’s technology will play a central role in the births of tens of millions of people in the coming years by reducing the risk of loss or misidentification of the priceless cells used in IVF. Our automation eliminates error-prone manual tasks in the embryology lab, allowing embryologists to focus on the most skilled and technical aspects of their work. In 2021, TMRW ivfOS was recognized as one of Fast Company's World Changing Ideas in the Software Category.
Total Funding: N/A
Funding Stage: N/A
Business Stage: Scaling Up
Market: B2C
Company Size: 101 to 250
Founded: 2018
Oct 2021
- CCRM Fertility Colorado and TMRW Life Sciences Partners in State-of-the-Art Technology
Jun 2021
- Boston IVF Partners with TMRW Life Sciences to Adopt State-of-the-Art Technology
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at TMRW Life Sciences
